Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 2
2018 3
2019 2
2020 5
2021 4
2022 2
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
CD38 expression by plasma cells in extramedullary multiple myeloma.
Notarfranchi L, Accardi F, Mancini C, Martella E, Bonomini S, Segreto R, Vescovini R, Palma ABD, Sammarelli G, Todaro G, Storti P, Burroughs-Garcia J, Iannozzi NT, Raimondi V, Lungu O, Ricci S, Craviotto L, Giuliani N. Notarfranchi L, et al. Haematologica. 2024 Apr 1;109(4):1297-1300. doi: 10.3324/haematol.2023.284169. Haematologica. 2024. PMID: 37941401 Free PMC article. No abstract available.
Mechanisms of Action of the New Antibodies in Use in Multiple Myeloma.
Romano A, Storti P, Marchica V, Scandura G, Notarfranchi L, Craviotto L, Di Raimondo F, Giuliani N. Romano A, et al. Among authors: notarfranchi l. Front Oncol. 2021 Jul 8;11:684561. doi: 10.3389/fonc.2021.684561. eCollection 2021. Front Oncol. 2021. PMID: 34307150 Free PMC article. Review.
Hairy cell leukaemia mimicking multiple myeloma.
Notarfranchi L, Russo F, Re F, Mancini C, Martella E, Falini B, Aversa F, Tiacci E. Notarfranchi L, et al. Lancet Oncol. 2019 Mar;20(3):e187. doi: 10.1016/S1470-2045(18)30609-0. Lancet Oncol. 2019. PMID: 30842062 No abstract available.
Identification of PSMB4 and PSMD4 as novel target genes correlated with 1q21 amplification in patients with smoldering myeloma and multiple myeloma.
Garcia JB, Storti P, Iannozzi NT, Marchica V, Agnelli L, Toscani D, Franceschi V, Todaro G, Sammarelli G, Notarfranchi L, Scita M, Palma BD, Raimondi V, Lungu O, Pruneri G, Donofrio G, Giuliani N. Garcia JB, et al. Among authors: notarfranchi l. Haematologica. 2024 Feb 1;109(2):627-631. doi: 10.3324/haematol.2023.283200. Haematologica. 2024. PMID: 37608776 Free PMC article. No abstract available.
The impact of CD56 expression in smoldering myeloma patients on early progression.
Notarfranchi L, Segreto R, Vescovini R, Dalla Palma AB, Marchica V, Burroughs-Garcia J, Toscani D, Todaro G, Raimondi V, Iannozzi NT, Bonomini S, Sammarelli G, Craviotto L, Pedrazzoni M, Storti P, Giuliani N. Notarfranchi L, et al. Hematol Oncol. 2023 Aug;41(3):587-589. doi: 10.1002/hon.3104. Epub 2022 Dec 1. Hematol Oncol. 2023. PMID: 36441875 No abstract available.
Neurofibromatosis type I and multiple myeloma coexistence: A possible link?
Accardi F, Marchica V, Mancini C, Maredi E, Racano C, Notarfranchi L, Martorana D, Storti P, Martella E, Palma BD, Craviotto L, Filippo M, Percesepe A, Aversa F, Giuliani N. Accardi F, et al. Among authors: notarfranchi l. Hematol Rep. 2018 Apr 3;10(1):7457. doi: 10.4081/hr.2018.7457. eCollection 2018 Mar 2. Hematol Rep. 2018. PMID: 29721253 Free PMC article.
Immune response to SARS-CoV-2 mRNA vaccination and booster dose in patients with multiple myeloma and monoclonal gammopathies: impact of Omicron variant on the humoral response.
Storti P, Marchica V, Vescovini R, Franceschi V, Russo L, Notarfranchi L, Raimondi V, Toscani D, Burroughs Garcia J, Costa F, Dalla Palma B, Iannozzi NT, Sammarelli G, Donofrio G, Giuliani N. Storti P, et al. Among authors: notarfranchi l. Oncoimmunology. 2022 Sep 6;11(1):2120275. doi: 10.1080/2162402X.2022.2120275. eCollection 2022. Oncoimmunology. 2022. PMID: 36105747 Free PMC article.
Mesangiogenic progenitor cells are forced toward the angiogenic fate, in multiple myeloma.
Pacini S, Montali M, Mazziotta F, Schifone CP, Macchia L, Carnicelli V, Panvini FM, Barachini S, Notarfranchi L, Previti GB, Buda G, Petrini M. Pacini S, et al. Among authors: notarfranchi l. Oncotarget. 2019 Nov 26;10(63):6781-6790. doi: 10.18632/oncotarget.27285. eCollection 2019 Nov 26. Oncotarget. 2019. PMID: 31827721 Free PMC article.
Application of Next-Generation Sequencing for the Genomic Characterization of Patients with Smoldering Myeloma.
Manzoni M, Marchica V, Storti P, Ziccheddu B, Sammarelli G, Todaro G, Pelizzoni F, Salerio S, Notarfranchi L, Pompa A, Baldini L, Bolli N, Neri A, Giuliani N, Lionetti M. Manzoni M, et al. Among authors: notarfranchi l. Cancers (Basel). 2020 May 23;12(5):1332. doi: 10.3390/cancers12051332. Cancers (Basel). 2020. PMID: 32456143 Free PMC article.
16 results